Lv1
60 积分 2023-08-07 加入
A paradigm of cancer immunotherapy based on 2-[18F]FDG and anti-PD-L1 mAb combination to enhance the anti-tumor effect
3个月前
已完结
Natural killer cell therapies
6个月前
已完结
Advances in Radionuclide-Labeled Biological Carriers for Tumor Imaging and Treatment
6个月前
已完结
Quantitative 18F-FDG PET/CT Model for predicting pathological complete response to neoadjuvant immunochemotherapy in NSCLC: comparison with RECIST 1.1 and PERCIST
7个月前
已完结
皖公网安备34019202002308
